bio 316 presentation - acute myeloid leukemia (aml)

Upload: angelostojanovski

Post on 07-Apr-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)

    1/14

    ACUTE MYELOID LEUKEMIAACUTE MYELOID LEUKEMIA

    (AML)(AML)

    Presented by Judi McCarter

  • 8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)

    2/14

    Clinical Overview

    Acute myeloid leukemia (AML) is one of four types ofleukemia.

    AML is cancer of the blood-forming tissue (bone marrow).

    Normal bone marrow produces red cells, white cells, and

    platelets. AML causes bone marrow to produce too many immature

    white blood cells (blast cells).

    Suppresses normal blood cell production.

    Anemia, leucopenia, thrombocytopenia

  • 8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)

    3/14

  • 8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)

    4/14

  • 8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)

    5/14

  • 8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)

    6/14

    Signs and Symptoms

    Fatigue

    Shortness of breath on exertion

    Easy bruising

    Petechiae

    Bleeding in the nose or from the gums

    Prolonged bleeding from minor cuts

    Recurrent minor infections or poor healing of minor cuts Loss of appetite or weight loss

    Mild fever

  • 8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)

    7/14

    11,920 new cases expected in U.S. in 2004

    8,870 estimated deaths 2004 M:54%, F:46%

    Statistics

    5-year survival rate in adults under 65 is 33%

    5-year survival rate in adults over 65 is 4%

    Incidence:

    Mortality:

    Prognosis:

    Prognosis:

    Prognosis:

    Incidence:

    Mortality:

    Prognosis:

    Prognosis:

    Prognosis: 20-30% experience remission or are cured

    Sources: American Cancer Society, 2003; The Leukemia & Lymphoma Society, 2003

  • 8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)

    8/14

    Risk Factors Age

    Older adults are more likely to develop AML

    Smoking 20% of AML cases are linked to smoking

    Doubles the risk of disease in people older than 60 Genetic disorders

    Down syndrome, Fanconis anemia

    High doses of radiation Long-term survivors of atomic bombs

    Previous chemotherapy treatment Breast cancer, ovarian cancer, lymphoma

    Exposure to industrial chemicals Benzene

  • 8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)

    9/14

    Treatments for AML

    Chemotherapy

    Phase One Remission induction therapy

    Phase Two Remission continuation therapy Radiation therapy for certain cases

    Bone marrow transplantation

  • 8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)

    10/14

  • 8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)

    11/14

    The Future

    Clinical trials

    New drug treatments

    Vaccines

    Immunotherapy

    Leukemia type-specific therapy

    Gene therapy Block encoding instructions of an oncogene

    Target the oncoprotein

    Blood and marrow stem cell transplantation Bone marrow transplantation provides long-term, disease-freesurvival among patients in remission

  • 8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)

    12/14

    Jillian had leukemia. She was only

    one year old. She needed a

    transplant, but no one in her family

    was a match. Joe had joined the

    Registry at the encouragement of a

    friend. Brought together by the

    National Marrow Donor Program,

    this donor and recipient now have alife-long connection.

    http://www.marrow.org

  • 8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)

    13/14

    1-800-4MY-SDBB 1-800-469-7322

  • 8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)

    14/14

    Questions??

    Thank you.